H2O Clinical LLC Report issue

For profit Phase 2 Phase 4
Founded: Hunt Valley MD United States (2010)
Status: Acquired by Firma Clinical Research (2017)

Organization Overview

First Clinical Trial
2013
NCT01936649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

iobenguane (123i) (1 trial)

Drugs in Phase 2 Trials (1)

estradiol (progynon depot) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 2)

Ventricular Dysfunction (Phase 4)

Ventricular Dysfunction, Left (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2